Stockreport

Endocyte in-licenses late-stage prostate cancer candidate from ABX GmbH; shares ahead 11% premarket [Seeking Alpha]

ENDOCYTE  (ECYT) 
Last endocyte earnings: 11/7 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.endocyte.com/investor-relations
PDF Endocyte in-licenses late-stage prostate cancer candidate from ABX GmbH; shares ahead 11% premarketThinly traded nano cap Endocyte (NASDAQ:ECYT) is up11% premarket on ro [Read more]